Civic Intelligence

Advanced Regenerative Manufacturing

990 • Fiscal year 2022 • EIN 81-3327581

Jan 01, 2022 to Dec 31, 2022 • Filed on Dec 17, 2025

Organization Profilewww.armiusa.org

View Organization Page

Refreshing map…

400 Commercial StManchester, NH 03101

(603) 666-3905

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

61st percentile

0.40x

Higher debt load relative to assets than 61% of similar nonprofits.

2022 filings • 501(c)6 • $25M-$50M nonprofits • Source year 2022

Liabilities / Revenue

39th percentile

0.38x

Higher debt load relative to revenue than 39% of similar nonprofits.

2022 filings • 501(c)6 • $25M-$50M nonprofits • Source year 2022

Net Margin

60th percentile

8.5%

Higher net margin than 60% of similar nonprofits.

2022 filings • 501(c)6 • $25M-$50M nonprofits • Source year 2022

Top Officer Pay

15th percentile

$228,264

Higher top officer pay than 15% of similar nonprofits.

Top officer pay equals 0.8% of source-year revenue.

2022 filings • 501(c)6 • $25M-$50M nonprofits • Source year 2022

Asset Growth

83rd percentile

27%

Faster asset growth than 83% of similar nonprofits.

2022 filings • 501(c)6 • $25M-$50M nonprofits • Annualized from 2021 to 2022

Revenue Growth

61st percentile

13%

Faster revenue growth than 61% of similar nonprofits.

2022 filings • 501(c)6 • $25M-$50M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets61st percentile

Assets

Up

$28,649,661

Up $6,012,107 (+27%) from 2021

Net Assets

Up

$17,164,957

Up $2,561,644 (+18%) from 2021

Liabilities

Up

$11,484,704

Up $3,450,463 (+43%) from 2021

Revenue And Expenses
Liabilities / Revenue39th percentileNet Margin60th percentile

Revenue

Up

$30,061,391

Up $3,500,371 (+13%) from 2021

Expenses

Up

$27,499,747

Up $5,947,200 (+28%) from 2021

Net Income

Down

$2,561,644

Down $2,446,829 (-49%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth83rd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$40M$30M$20M$10M$0Assets 2017: $1,340,964Liabilities 2017: $1,067,165Net Assets 2017: $273,7992017Assets 2018: $3,623,804Liabilities 2018: $842,081Net Assets 2018: $2,781,7232018Assets 2019: $9,593,362Liabilities 2019: $4,409,713Net Assets 2019: $5,183,6492019Assets 2020: $17,423,174Liabilities 2020: $7,828,334Net Assets 2020: $9,594,8402020Assets 2021: $22,637,554Liabilities 2021: $8,034,241Net Assets 2021: $14,603,3132021Assets 2022: $28,649,661Liabilities 2022: $11,484,704Net Assets 2022: $17,164,9572022Assets 2023: $29,045,430Liabilities 2023: $11,371,178Net Assets 2023: $17,674,2522023Assets 2024: $37,903,038Liabilities 2024: $17,623,664Net Assets 2024: $20,279,3742024

Highlighted filing

2022

Assets$28,649,661
Liabilities$11,484,704
Net Assets$17,164,957
Open 2022 Filing

Operations Trend

Revenue Growth61st percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$60M$40M$20M$0Revenue 2017: $2,456,227Expenses 2017: $2,182,428Net Income 2017: $273,7992017Revenue 2018: $5,212,381Expenses 2018: $2,704,457Net Income 2018: $2,507,9242018Revenue 2019: $10,942,647Expenses 2019: $8,540,721Net Income 2019: $2,401,9262019Revenue 2020: $23,960,299Expenses 2020: $19,549,108Net Income 2020: $4,411,1912020Revenue 2021: $26,561,020Expenses 2021: $21,552,547Net Income 2021: $5,008,4732021Revenue 2022: $30,061,391Expenses 2022: $27,499,747Net Income 2022: $2,561,6442022Revenue 2023: $26,819,069Expenses 2023: $26,309,774Net Income 2023: $509,2952023Revenue 2024: $41,521,294Expenses 2024: $38,916,172Net Income 2024: $2,605,1222024

Highlighted filing

2022

Revenue$30,061,391
Expenses$27,499,747
Net Income$2,561,644
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Dec 17, 2025
Return Version
2022v5.0
Gross Receipts
$30,061,391
Mission and Program Overview

Mission

ARMI's mission is to support advanced tissue biofabrication.

ARMI's mission is to support, develop, advance and promote the United States bioeconomy.

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$9,272,970$10,652,869▲ $1,379,899
Savings and Temporary Cash Investments$8,079,318$9,697,118▲ $1,617,800
Accounts Receivable$4,481,342$4,452,276▼ $29,066
Prepaid Expenses and Deferred Charges$352,893$398,735▲ $45,842
Cash and Non-Interest-Bearing Accounts$362,019$224,206▼ $137,813
Intangible Assets$89,012$119,415▲ $30,403
Total Assets$22,637,554$28,649,661▲ $6,012,107
Other Assets Total$0$3,105,042▲ $3,105,042
Liabilities
Accounts Payable and Accrued Expenses$7,014,812$6,919,240▼ $95,572
Other Liabilities$0$3,105,042▲ $3,105,042
Deferred Revenue$1,019,429$1,460,422▲ $440,993
Total Liabilities$8,034,241$11,484,704▲ $3,450,463
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$14,603,313$17,164,957▲ $2,561,644
Total Net Assets Fund Balance$14,603,313$17,164,957▲ $2,561,644
Total Liabilities and Net Assets / Fund Balance$22,637,554$28,649,661▲ $6,012,107

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$5,742,408$3,334,697$9,077,105
Leasehold Improvements$4,910,461$246,414$5,156,875
Other Assets Org$3,105,042--
Compensation and Service Providers
Top Officer Pay15th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Edward GordonChief Operating Officer - BioFabFT$192,727$35,537$228,264
Richard McFarlandChief Regulatory OfficerFT$195,289$26,263$221,552
Julie LenzerChief Innovation OfficerFT$178,100$15,533$193,633
Kelly MorbeyDirector of Regulatory Affairs &QAFT$155,000$11,960$166,960
Jeremiah WilleSr Regulatory Affairs SpecialistFT$160,000$594$160,594

Board Members and Trustees

NameTitle
Blake MoretBoard Member
Jim WeinsteinBoard Member
John AbeleBoard Member
Martine RothblattBoard Member
Maureen TooheyDeputy Executive Director
Dean KamenExecutive Director
James ScottChief Operating Officer
Brendan DuffyTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Nexight Group LLCConsultant - HHS Programs1100 Wayne Avenue Suite 1100, Silver Spring, MD 20910$284,332
-Consultant77 South Street, Portsmouth, NH 03801$142,000
Revenue and Support

Revenue Composition

Contributions and Grants
$28,539,924
Program Service Revenue
$1,511,772
Investment Income
$9,695
Other Revenue
$0
All Other Contributions
$1,332,086
Change in Net Assets
$2,561,644

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
Yes
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Other Non Cash Contri Table5$183,408Fair Market Value (FMV)
Total Noncash Contributions5$183,408-
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$14,140,651
Other Expenses$8,174,050
Salaries, Compensation, and Employee Benefits$5,185,046
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs---$12,167,782
Other Salaries and Wages---$4,364,797
Other Expenses---$2,087,636
Foreign Grants---$1,972,869
Depreciation Depletion---$1,772,751
Fees for Services Other---$1,473,833
Occupancy---$1,092,552
Conferences and Meetings---$773,924
Other Employee Benefits---$395,284
Information Technology---$378,382
Payroll Taxes---$332,955
Office Expenses---$290,724
Travel---$171,791
Pension Plan Contributions---$92,010
Fees for Services Accounting---$45,420
Insurance---$44,508
Advertising---$42,529
Total Functional Expenses$0$0$0$27,499,747
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
DEKA Integrated Solutions CorpManchester, NH-BiofabUSA CARES Act Funded Program (DOD-Directed)$4,163,867
MxD USAChicago, IL501(c)(3)BioFabUSA CARES Act Funded Program (DoD-Directed)$872,244
Advanced Solutions IncLouisville, KY501(c)(3)See Part IV$663,432
PluristyxSeattle, WA-See Part IV$643,723
X-ThermaSan Pablo, CA-Subaward pursuant to our Technology Investment Agreement with the Government$632,120
Washington UniversitySt Louis, MO-Subaward pursuant to our grant with a private foundation$497,249
Organamet BioMontgomery, AL-Subaward pursuant to our Technology Investment Agreement with the Government$489,766
University of FloridaAtlanta, GA-Subaward pursuant to our Technology Investment Agreement with the Government$378,792
Terasaki Institute for Biomedical InnovatLos Angeles, CA-Subaward pursuant to our Technology Investment Agreement with the Government$316,224
The General Hospital Corporation dba Massachusetts General HospitalBoston, MA-NextFab Bilateral Health Tech Hub Program (HHS-Directed)$308,773
DEKA Research & Development CorpManchester, NH-NextFab Bilateral Health Tech Hub Program (HHS-Directed)$254,829
DEKA Integrated Solutions CorpManchester, NH501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$224,911
Arizona State UniversityTempe, AZ501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$215,188
Dartmouth CollegeHanover, NH501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$211,116
Applied BiosensorsSalt Lake City, UT501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$176,723
EpiboneJersey City, NJ501(c)(3)See Part IV$176,564
Rutgers UniversityPiscataway, NJ-Subaward pursuant to our Technology Investment Agreement with the Government$171,757
University of VirginiaCharlottesville, VA-Subaward pursuant to our Technology Investment Agreement with the Government$155,369
Southwest Research InstituteSan Antonio, TX-Subaward pursuant to our Technology Investment Agreement with the Government$152,101
Sudhin Biopharma CoSuperior, CO-Subaward pursuant to our Technology Investment Agreement with the Government$150,341
Georgia Tech Research CorpAtlanta, GA501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$141,509
Cornell University - Biomedical EngIthaca, NY501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$132,438
Trailhead Biosystems IncBeachwood, OH-See Part IV$115,177
IncellSan Antonio, TX501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$94,001
Biogen MA IncCambridge, MA501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$89,610
Stratatech Corp Mallinckrodt PharmHazelwood, MO-Subaward pursuant to our Technology Investment Agreement with the Government$83,644
University of New HampshireDurham, NH-See Part IV$77,554
University of Notre Dame (ND)Notre Dame, IN-Subaward pursuant to our Technology Investment Agreement with the Government$74,782
Standards Coordinating BodyGaithersburg, MD-Subaward pursuant to our Technology Investment Agreement with the Government$68,720
WpiWorcester, MA-Subaward pursuant to our Technology Investment Agreement with the Government$63,843
Brown UniverisityProvidence, RI501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$63,629
Axogen CorpAlachua, FL501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$57,893
Blood Cell Storage IncSeattle, WA501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$57,643
RoosterBioFederick, MD-Subaward pursuant to our Technology Investment Agreement with the Government$42,695
Massachusetts Institute of TechCambridge, MA501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$32,885
NeuriteBirmingham, AL-BioFabUSA CARES Act Funded Program (DoD-Directed)$26,024
SEE Science Center IncManchester, NH-Subaward pursuant to our Technology Investment Agreement with the Government$18,323
ChromoLogic LLCMonrovia, CA501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$15,637
AsymmetrexBoston, MA501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$14,621
Texas A&M Engineering Experiment StationCollege Station, TX-Subaward pursuant to our Technology Investment Agreement with the Government$13,451
Girl Scouts of the Green and White MntsBedford, NH501(c)(3)Subaward pursuant to our Technology Investment Agreement with the Government$11,800
Sentien BiotechnologiesLexington, MA-Subaward pursuant to our Technology Investment Agreement with the Government$10,950

International Summary

Offices
0
Employees
0
Spending
$1,972,869

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
NetherlandsGrant - BioFab USA Cares Act Funded Program (DoD Directed)-00$1,350,819
IsraelGrant - NextFab Bilateral Health Tech Hub Program (HHS-Directed)-00$622,050
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
In-house lobbying only
Yes
Subject to proxy tax
Yes
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
-See Part VRent paidNo$469,858
-See Part VRent paidNo$188,436
-See Part VRent paidNo$131,754
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Lease Obligations$3,105,042
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, line 2

“James Scott and Brendan Duffy are employees of DEKA, a company owned by Dean Kamen. Maureen Toohey is a member of the Toohey Law Group. The executive director Dean Kamen and board member Martine Rothblatt are directors at Beta Technologies.”

Form 990, Part VI, Section A, line 6

“ARMI is a membership based organization consisting of organizations with interests and/or experience with regenerative medicine and manufacturing in the United States.”

Form 990, Part VI, Section B, line 11B

“Key members of management review and comment on the 990 and it is distributed to all board members prior to filing with the Internal Revenue Service.”

Form 990, Part VI, Section B, line 12C

“The conflict of interest policy is included on ARMI's internal server, and is posted online on its member portal. Any new employees or officers are provided a copy of this when joining ARMI. Any conflicts are to be reported to the Executive Director or ARMI legal counsel.”

Form 990, Part VI, Section C, line 19

“Upon Request”

Form 990, Part VII, Section A:

“As part of its startup activities, per its proposal to the government, the Organization (ARMI) does not pay compensation to some of its officers. Instead, these officers are compensated by member organization DEKA, an unrelated third party, through a government cost share agreement between ARMI and DEKA. DEKA does not treat these compensation payments as a charitable contribution to ARMI; therefore, the compensation is not required to be shown on Part VII, Section A, Line 1a.”

Filing and Contact Details

Filer

Filer Name
Advanced Regenerative Manufacturing
EIN
81-3327581
Phone
6036663905
Address
400 Commercial St, Manchester, NH 03101

Signing Officer

Name
Jennifer MacDonald
Title
Chief Operating Officer
Phone
6036663905
Signed
2025-12-17
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Maureen Toohey
Formed
2016
Legal Domicile
Nh
Voting Board Members
5
Independent Board Members
5
Employees
64
Volunteers
150

Preparer

Firm
Berry Dunn McNeil & Parker LLC
Address
2211 Congress St, Portland, ME 04102
Preparer
Melissa Magoon CPA
Phone
2077752387
Supplemental Narrative

Additional Explanations

Form 990, Explanation of Changes to Amended Return:

“The 2022 Form 990 is being amended for thoroughness and consistency. 1. Schedule L is amended to provide additional detail in Part V. 2. Part VI, Line 2 of Schedule O is updated.”

Financial Statement Notes

Part X, Line 2:

“ARMI, Inc. is a not-for-profit corporation, as described under Section 501(c)(6) of the Internal Revenue Code, exempt from federal and state income taxes on income related to the fulfillment of ARMI, Inc.'s mission. Accordingly, no income tax expense for ARMI, Inc. has been reported in these financial statements. BioIndustries is a taxable entity and files a federal income tax return. Deferred taxes related to BioIndustries are based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect in the years the differences are expected to reverse. Management has evaluated BioIndustries' tax positions and determined that there are no tax positions requiring accounting recognition. Income tax returns filed by BioIndustries are subject to examination by the Internal Revenue Service for a period of three years. While no income tax returns are currently being examined by the Internal Revenue Service, the two previous tax years remain open. No interest or penalties from federal or state tax authorities were recorded in the accompanying consolidated financial statements.”

Raw XML AppendixShowing 400 of 1,029 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt07014812
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt06919240
IRS990/AccountsReceivableGrp/BOYAmt04481342
IRS990/AccountsReceivableGrp/EOYAmt04452276
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0ARMI's mission is to support, develop, advance and promote the United States bioeconomy.
IRS990/AdvertisingGrp/TotalAmt042529
IRS990/AllOtherContributionsAmt01332086
IRS990/AmendedReturnInd0X
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0Thomas Deyak CPA
IRS990/BooksInCareOfDetail/PhoneNum06036663905
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0400 Commercial St
IRS990/BooksInCareOfDetail/USAddress/CityNm0Manchester
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NH
IRS990/BooksInCareOfDetail/USAddress/ZIPCd003101
IRS990/BusinessRlnWith35CtrlEntInd01
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0362019
IRS990/CashNonInterestBearingGrp/EOYAmt0224206
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt03
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/TotalAmt0773924
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt0284332
IRS990/ContractorCompensationGrp/CompensationAmt1142000
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt01100 Wayne Avenue Suite 1100
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt177 South Street
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0Silver Spring
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1Portsmouth
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1NH
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd020910
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd103801
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0Nexight Group LLC
IRS990/ContractorCompensationGrp/ContractorName/PersonNm0Stefany Shaheen
IRS990/ContractorCompensationGrp/ServicesDesc0Consultant - HHS Programs
IRS990/ContractorCompensationGrp/ServicesDesc1Consultant
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt028539924
IRS990/CYGrantsAndSimilarPaidAmt014140651
IRS990/CYInvestmentIncomeAmt09695
IRS990/CYOtherExpensesAmt08174050
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt01511772
IRS990/CYRevenuesLessExpensesAmt02561644
IRS990/CYSalariesCompEmpBnftPaidAmt05185046
IRS990/CYTotalExpensesAmt027499747
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt030061391
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd01
IRS990/DeferredRevenueGrp/BOYAmt01019429
IRS990/DeferredRevenueGrp/EOYAmt01460422
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/TotalAmt01772751
IRS990/Desc0ARMI and its BioFabUSA Institute accomplishes its mission through key activities, such as the following: Collaborates with community, local, State, and Federal stakeholders to advance the U.S bioeconomy and fuel inclusive economic growth, including by creating pathways and access to jobs in the biofabrication industry. Provides wrap-around commercialization services for tissue engineering and enabling technology companies. These efforts de-risk and accelerate translation of impactful technologies to market. Funds technical projects that address many of the common manufacturing challenges faced by companies in the field of tissue engineering. This will allow tissue engineering and enabling technology companies to focus their time and resources on product-specific challenges, moving the entire industry forward more quickly and efficiently. Funds education and workforce development (EWD) projects that address the industry need for trained employees with a broad base of biomanufacturing skills and specific expertise. This pressing need can otherwise constrain the growth of tissue engineering and enabling technology companies. In coordination with organizations in the field of regenerative manufacturing, develops roadmaps of technical and EWD needs for the field. These roadmaps guide the work of organizations in the field of regenerative manufacturing and guide the selection of projects. Hosts, sponsors, and participates in conferences and workshops that convene organizations that support regenerative manufacturing. These events allow for shared learning related to technical, regulatory, workforce, and financial challenges and solutions. Shares information about best practices and innovations in the field via various fora and online resources.NextFab accomplishes is mission through key activities, such as the following: Establish framework for demand-based Advisory Panels to conduct expert seminars and other thought-leadership efforts. Develop commercial advisory and consulting programs designed to accelerate adoption of advanced technologies. Provide shared facilities to accelerate advanced technologies. Performs projects of interest to U.S. Department of Health and Human Services.
IRS990/DescribedInSection501c3Ind00
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt064
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditPerformedInd01
IRS990/FederalGrantAuditRequiredInd01
IRS990/FeesForServicesAccountingGrp/TotalAmt045420
IRS990/FeesForServicesOtherGrp/TotalAmt01473833
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/TotalAmt01972869
IRS990/ForeignOfficeInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt05.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt525.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt615.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt826263
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt935537
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1015533
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt11594
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1211960
IRS990/Form990PartVIISectionAGrp/PersonNm0Dean Kamen
IRS990/Form990PartVIISectionAGrp/PersonNm1Martine Rothblatt
IRS990/Form990PartVIISectionAGrp/PersonNm2John Abele
IRS990/Form990PartVIISectionAGrp/PersonNm3Jim Weinstein
IRS990/Form990PartVIISectionAGrp/PersonNm4Blake Moret
IRS990/Form990PartVIISectionAGrp/PersonNm5Maureen Toohey
IRS990/Form990PartVIISectionAGrp/PersonNm6James Scott
IRS990/Form990PartVIISectionAGrp/PersonNm7Brendan Duffy
IRS990/Form990PartVIISectionAGrp/PersonNm8Richard McFarland
IRS990/Form990PartVIISectionAGrp/PersonNm9Edward Gordon
IRS990/Form990PartVIISectionAGrp/PersonNm10Julie Lenzer
IRS990/Form990PartVIISectionAGrp/PersonNm11Jeremiah Wille
IRS990/Form990PartVIISectionAGrp/PersonNm12Kelly Morbey
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8195289
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9192727
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10178100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11160000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12155000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/TitleTxt0Executive Director
IRS990/Form990PartVIISectionAGrp/TitleTxt1Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt2Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt3Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt4Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt5Deputy Executive Director
IRS990/Form990PartVIISectionAGrp/TitleTxt6Chief Operating Officer
IRS990/Form990PartVIISectionAGrp/TitleTxt7Treasurer
IRS990/Form990PartVIISectionAGrp/TitleTxt8Chief Regulatory Officer
IRS990/Form990PartVIISectionAGrp/TitleTxt9Chief Operating Officer - BioFab
IRS990/Form990PartVIISectionAGrp/TitleTxt10Chief Innovation Officer
IRS990/Form990PartVIISectionAGrp/TitleTxt11Sr Regulatory Affairs Specialist
IRS990/Form990PartVIISectionAGrp/TitleTxt12Director of Regulatory Affairs &QA
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02016
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GovernmentGrantsAmt027207838
IRS990/GrantsToDomesticOrgsGrp/TotalAmt012167782
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd01
IRS990/GrossReceiptsAmt030061391
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt05
IRS990/IndivRcvdGreaterThan100KCnt012
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/TotalAmt0378382
IRS990/InsuranceGrp/TotalAmt044508
IRS990/IntangibleAssetsGrp/BOYAmt089012
IRS990/IntangibleAssetsGrp/EOYAmt0119415
IRS990/InvestmentIncomeGrp/ExclusionAmt09695
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt09695
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt035
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt03581111
IRS990/LandBldgEquipBasisNetGrp/BOYAmt09272970
IRS990/LandBldgEquipBasisNetGrp/EOYAmt010652869
IRS990/LandBldgEquipCostOrOtherBssAmt014233980
IRS990/LegalDomicileStateCd0NH
IRS990/LoanOutstandingInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0ARMI's mission is to support, develop, advance and promote the United States bioeconomy.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt014603313
IRS990/NetAssetsOrFundBalancesEOYAmt017164957
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt014603313
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt017164957
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NoncashContributionsAmt0183408
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/TotalAmt01092552
IRS990/OfficeExpensesGrp/TotalAmt0290724
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501cInd0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt00
IRS990/OtherAssetsTotalGrp/EOYAmt03105042
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0395284
IRS990/OtherExpensesGrp/Desc0Lab Materials & Supplie
IRS990/OtherExpensesGrp/TotalAmt02087636
IRS990/OtherLiabilitiesGrp/BOYAmt00
IRS990/OtherLiabilitiesGrp/EOYAmt03105042
IRS990/OtherSalariesAndWagesGrp/TotalAmt04364797
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/TotalAmt0332955
IRS990/PensionPlanContributionsGrp/TotalAmt092010
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0352893
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0398735
IRS990/PrincipalOfficerNm0Maureen Toohey
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0541700
IRS990/ProgramServiceRevenueGrp/BusinessCd1541700
IRS990/ProgramServiceRevenueGrp/BusinessCd2541700
IRS990/ProgramServiceRevenueGrp/Desc0Membership Dues
IRS990/ProgramServiceRevenueGrp/Desc1Other Program Revenue
IRS990/ProgramServiceRevenueGrp/Desc2Management Fee Revenue
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt01098702
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt1221167
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt2191903
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt01098702
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt1221167
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt2191903
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt025317444
IRS990/PYGrantsAndSimilarPaidAmt013091692
IRS990/PYInvestmentIncomeAmt08405
IRS990/PYOtherExpensesAmt04920692
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt01235171
IRS990/PYRevenuesLessExpensesAmt05008473
IRS990/PYSalariesCompEmpBnftPaidAmt03540163
IRS990/PYTotalExpensesAmt021552547
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt026561020
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt02561644
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt08079318
IRS990/SavingsAndTempCashInvstGrp/EOYAmt09697118
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/AgreeCarryoverPriorYearInd00
IRS990ScheduleC/OnlyInHouseLobbyingInd01
IRS990ScheduleC/SubstantiallyAllDuesNondedInd00
IRS990ScheduleD/EquipmentGrp/BookValueAmt05742408
IRS990ScheduleD/EquipmentGrp/DepreciationAmt03334697
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt09077105
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt04910461
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0246414
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt05156875
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt03105042
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0Right-of-use Assets
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt03105042
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0Lease Obligations
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0ARMI, Inc. is a not-for-profit corporation, as described under Section 501(c)(6) of the Internal Revenue Code, exempt from federal and state income taxes on income related to the fulfillment of ARMI, Inc.'s mission. Accordingly, no income tax expense for ARMI, Inc. has been reported in these financial statements. BioIndustries is a taxable entity and files a federal income tax return. Deferred taxes related to BioIndustries are based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect in the years the differences are expected to reverse. Management has evaluated BioIndustries' tax positions and determined that there are no tax positions requiring accounting recognition. Income tax returns filed by BioIndustries are subject to examination by the Internal Revenue Service for a period of three years. While no income tax returns are currently being examined by the Internal Revenue Service, the two previous tax years remain open. No interest or penalties from federal or state tax authorities were recorded in the accompanying consolidated financial statements.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0Part X, Line 2:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt010652869
IRS990ScheduleD/TotalBookValueOtherAssetsAmt03105042
IRS990ScheduleD/TotalLiabilityAmt03105042
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt01350819
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt1622050
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0Netherlands
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1Israel
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0Grant - BioFab USA Cares Act Funded Program (DoD Directed)
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1Grant - NextFab Bilateral Health Tech Hub Program (HHS-Directed)
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt01350819
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt1422050
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt2200000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0Wire transfer
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt1Wire transfer
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt2Wire transfer
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt10
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt20
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0BioFab USA CARES Act Funded Program (DoD Directed)
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt1NextFab Bilateral Health Tech Hub Program (HHS-Directed)
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt2NextFab Bilateral Health Tech Hub Program (HHS-Directed)
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0Netherlands
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt1Israel
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt2Israel
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt01972869
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0ARMI's monitoring level is dependent on a risk assessment, which is completed on all subawards. Based on this assessment, ARMI performed procedures that included, but were not limited to, the following: o development of a written Statement of Work o periodic conference calls to review progress related to the Statement of Work o review of all deliverables prior to approval of invoices
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, Line 2:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc1Part III Accounting Method:
IRS990ScheduleF/Total501c3OrgCnt00
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalOtherOrgCnt03
IRS990ScheduleF/TotalSpentAmt01972869
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt0663432
IRS990ScheduleI/RecipientTable/CashGrantAmt1176723
IRS990ScheduleI/RecipientTable/CashGrantAmt2215188
IRS990ScheduleI/RecipientTable/CashGrantAmt314621
IRS990ScheduleI/RecipientTable/CashGrantAmt457893
IRS990ScheduleI/RecipientTable/CashGrantAmt589610
IRS990ScheduleI/RecipientTable/CashGrantAmt657643
IRS990ScheduleI/RecipientTable/CashGrantAmt763629
IRS990ScheduleI/RecipientTable/CashGrantAmt815637
IRS990ScheduleI/RecipientTable/CashGrantAmt9132438
IRS990ScheduleI/RecipientTable/CashGrantAmt10211116
IRS990ScheduleI/RecipientTable/CashGrantAmt11224911
IRS990ScheduleI/RecipientTable/CashGrantAmt12176564
IRS990ScheduleI/RecipientTable/CashGrantAmt13141509
IRS990ScheduleI/RecipientTable/CashGrantAmt1411800
IRS990ScheduleI/RecipientTable/CashGrantAmt1594001
IRS990ScheduleI/RecipientTable/CashGrantAmt1632885
IRS990ScheduleI/RecipientTable/CashGrantAmt17872244
IRS990ScheduleI/RecipientTable/CashGrantAmt1826024
IRS990ScheduleI/RecipientTable/CashGrantAmt19489766
IRS990ScheduleI/RecipientTable/CashGrantAmt20643723
IRS990ScheduleI/RecipientTable/CashGrantAmt2142695
IRS990ScheduleI/RecipientTable/CashGrantAmt22171757
IRS990ScheduleI/RecipientTable/CashGrantAmt2318323
IRS990ScheduleI/RecipientTable/CashGrantAmt2410950
IRS990ScheduleI/RecipientTable/CashGrantAmt25152101
IRS990ScheduleI/RecipientTable/CashGrantAmt2668720
IRS990ScheduleI/RecipientTable/CashGrantAmt2783644
IRS990ScheduleI/RecipientTable/CashGrantAmt28150341
IRS990ScheduleI/RecipientTable/CashGrantAmt29316224

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$28,649,661
Liabilities
$11,484,704
Net assets
$17,164,957
Revenue
$30,061,391
Expenses
$27,499,747
Net income
$2,561,644
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$37.9$17.6$20.3$41.5$38.9$2.61
2023Summary only. Only limited summary data is available for this year.$29.0$11.4$17.7$26.8$26.3$0.51
2022Detailed filing. Detailed filing data is available for this year.$28.6$11.5$17.2$30.1$27.5$2.56
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$22.6$8.03$14.6$26.6$21.6$5.01
2020Summary only. Only limited summary data is available for this year.$17.4$7.83$9.59$24.0$19.5$4.41
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.59$4.41$5.18$10.9$8.54$2.40
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$3.62$0.84$2.78$5.21$2.70$2.51
2017Summary only. Only limited summary data is available for this year.$1.34$1.07$0.27$2.46$2.18$0.27